63 related articles for article (PubMed ID: 23905345)
1. [Determination of recombinant hirudin in urine of rat by spectrophotometric method].
Jiang SY; Jiao J; Lu J; Xu YP; Dou GF
Guang Pu Xue Yu Guang Pu Fen Xi; 2013 May; 33(5):1327-30. PubMed ID: 23905345
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies with recombinant hirudin in dogs.
Nowak G; Markwardt F; Fink E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
[TBL] [Abstract][Full Text] [Related]
3. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
Zhang YJ; Wang XL; Wu JM; Cheng MX
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):801-4. PubMed ID: 17639978
[TBL] [Abstract][Full Text] [Related]
4. Studies for revealing a possible sensitization to hirudin after repeated intravenous injections in baboons.
Bichler J; Gemmerli R; Fritz H
Thromb Res; 1991 Jan; 61(1):39-51. PubMed ID: 1708530
[TBL] [Abstract][Full Text] [Related]
5. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
Komatsu Y; Hayashi H
Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
Jiang SY; Jiao J; Zhang TT; Xu YP
PLoS One; 2013; 8(6):e64336. PubMed ID: 23785400
[TBL] [Abstract][Full Text] [Related]
7. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
Iyer L; Koza M; Iqbal O; Calabria R; Fareed J
Thromb Res; 1993 Feb; 69(3):259-69. PubMed ID: 8475476
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
Kautzleben M; Stein G; Sperschneider H; Nowak G
Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
[TBL] [Abstract][Full Text] [Related]
9. [The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray].
Zhang YJ; Zhang Q; Hou JL; Wang XL; Chen MX
Yao Xue Xue Bao; 2006 Mar; 41(3):268-71. PubMed ID: 16759001
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
Liu Y; Lu WL; Zhang X; Wang XQ; Zhang H; Zhang Q
Peptides; 2005 Mar; 26(3):423-30. PubMed ID: 15652649
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Soria J; Soria C; Camez A; Mirshahi MC; Bassand JP
Thromb Haemost; 1994 May; 71(5):558-62. PubMed ID: 8091380
[TBL] [Abstract][Full Text] [Related]
12. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats.
Kusumoto K; Ido A; Moriuchi A; Katsura T; Kim I; Takahama Y; Numata M; Kodama M; Hasuike S; Nagata K; Uto H; Inui K; Tsubouchi H
Int J Mol Med; 2006 Mar; 17(3):503-9. PubMed ID: 16465399
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, distribution and excretion of PNA in rat by liquid chromatography mass spectrometry method.
Huang X; Jiang ZZ; Wang T; Li Z; Zhang LY; Zhang ZJ
Drug Res (Stuttg); 2013 Oct; 63(10):540-4. PubMed ID: 23794167
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and interspecies scaling of recombinant human factor VIII.
Mordenti J; Osaka G; Garcia K; Thomsen K; Licko V; Meng G
Toxicol Appl Pharmacol; 1996 Jan; 136(1):75-8. PubMed ID: 8560482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of 125I-hirudin in rats and dogs.
Richter M; Cyranka U; Nowak G; Walsmann P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):64-9. PubMed ID: 2459034
[TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of recombinant hirudin on fibrinolysis].
Li M; Zhang RJ; Cao GX; Wan WX; Zhang LF; Jin J
Yao Xue Xue Bao; 2006 Sep; 41(9):814-8. PubMed ID: 17111825
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
18. [Absorption of recombinant hirudin in rats GI tract].
Yan XY; Zhang XN; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):77-80. PubMed ID: 15127588
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of a tumour-targeting therapy candidate rh-IFNα2a-NGR with rh-IFNα2a administered intravenously in mice and rats.
Wang XX; Lu L; Song CL; Qian WN; Zhang SY; Zhang YQ; Wu YJ
J Pharm Pharmacol; 2013 Apr; 65(4):574-81. PubMed ID: 23488787
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of recombinant hirudin, a new anticoagulant.
Meyer BH; Luus HG; Müller FO; Badenhorst PN; Röthig HJ
S Afr Med J; 1990 Sep; 78(5):268-70. PubMed ID: 2392724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]